Detailed View
APGE - Apogee Therapeutics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
10,040,032,256
Adj EBIT (TTM)
-305,271,000
Enterprise Value
9,431,932,256
Last Price
133.54
Earnings Yield
-3.24%
Return on Capital
-24.21%
Capital
1,260,702,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -82,772,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -78,056,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -71,278,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -73,165,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -63,096,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -75,881,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -58,686,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -44,122,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.